Hemoperfusion With Efferon CT for the Treatment of Patients With Severe Psoriasis

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

February 27, 2026

Conditions
Psoriasis
Interventions
DEVICE

Efferon CT

"Efferon CT (JSC Efferon, Moscow, RF) is a device for extracorporeal blood purification by direct hemoperfusion. Detoxification is carried out by sorption of cytokines and other products of endogenous intoxication with a molecular size of up to 55 kDa.~The duration of hemoperfusion is from 2 to 6 hours through peripheral venous access, followed by follow-up for 4 hours. The rate of hemoperfusion is from 60 to 80 ml/min. Anticoagulation is systemic (heparin)."

Trial Locations (1)

Unknown

RECRUITING

North-Western State Medical University named after I.I. Mechnikov (NWSMU), Saint Petersburg

All Listed Sponsors
lead

Efferon JSC

INDUSTRY